Rating Indicators
What Caused Evaxion (EVAX) Stock to Drop Nearly 8% Pre-Market?
After gaining momentum in the last session for reaching a milestone, Evaxion Biotech A/S shares (Nasdaq: EVAX) were down -8.15% at $2.14 at pre-market. In
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.